Pharmaceutical Care for Patient with Pulmonary Aspergillosis Complicated with Rhabdomyolysis
10.6039/j.issn.1001-0408.2016.20.38
- VernacularTitle:肺曲霉病合并横纹肌溶解综合症患者的药学监护
- Author:
Jue LIU
;
Zhen WANG
- Publication Type:Journal Article
- Keywords:
Pulmonary aspergillosis;
Rhabdomyolysis;
Clinical pharmacists;
Pharmaceutical care
- From:
China Pharmacy
2016;27(20):2852-2854
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the role of clinical pharmacists in the therapy for patient with pulmonary aspergillosis complicated with rhabdomyolysis(RM). METHODS:Clinical pharmacists participated in the therapy for RM patients with pulmo-nary aspergillosis,and assisted physicians to optimize and improve therapy plan from RM therapy,anti-infection and liver protec-tion:stop taking Bicyclol tablet,continue Micafungin for injection 50 mg,ivgtt,qd for anti-infection;suspend liver-protective drug Compound glycyrrhizin;closely monitor therapeutic efficacy and ADR. RESULTS:Physicians adopted the suggestions of clini-cal pharmacists,and the situation of RM were improved. The patient were discharged from hospital 24 d later. CONCLUSIONS:Clinical pharmacists participate in therapy for RM patient with pulmonary aspergillosis and assist physicians to improve therapy plan,which contribute to rational drug use and the safety of drug use.
